Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)
Public ClinicalTrials.gov record NCT02955602. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An 8-week, Dose Ranging, Open Label, Randomized, Phase 2 Study With a 44-week Extension, to Evaluate the Safety and Efficacy of MBX-8025 in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or Intolerance to Ursodeoxycholic Acid (UDCA)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
An 8-week, dose ranging, open label, randomized, Phase 2 study with a 44-week extension, to evaluate the safety and efficacy of MBX-8025 in subjects with Primary Biliary Cholangitis (PBC) and an inadequate response to or intolerance to ursodeoxycholic acid (UDCA)
Study identification
- NCT ID
- NCT02955602
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 119 participants
Conditions and interventions
Conditions
Interventions
- MBX-8025 2 mg Capsule Drug
- MBX-8025 5 mg Capsule Drug
- MBX-8025 10 mg Capsule Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 28, 2016 (Actual)
- Primary completion
- Sep 7, 2018 (Actual)
- Completion
- Jul 8, 2019 (Actual)
- Last update posted
- Jul 14, 2022
2016 – 2019
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Institute for Liver Health | Chandler | Arizona | 85224 | — |
| Southern California Research Center | Coronado | California | 92118 | — |
| Standford University Medicine | Palo Alto | California | 94305 | — |
| University of California, Davis Medical Center | Sacramento | California | 95817 | — |
| Ventura Clinical Trials | Ventura | California | 93003 | — |
| Florida Research Institute | Lakewood Rch | Florida | 34211 | — |
| University of Miami - Center for Liver Diseases | Miami | Florida | 33136 | — |
| Atlanta Gastroenterology Associates, LLC | Atlanta | Georgia | 30308 | — |
| Digestive Healthcare of Georgia | Atlanta | Georgia | 30309 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Mercy Medical Center | Baltimore | Maryland | 21202 | — |
| Henry Ford Health System | Novi | Michigan | 48377 | — |
| University of Mississippi Medical Center | Jackson | Mississippi | 39216 | — |
| Saint Louis University, Gastroenterology & Hepatology | St Louis | Missouri | 63104 | — |
| Northwell Health - Center for Liver Disease and Transplantation | Manhasset | New York | 11030 | — |
| NYU Langone Medical Center | New York | New York | 10016 | — |
| The Mount Sinai Medical Center | New York | New York | 10029 | — |
| Northest Clinical Research Center, LLC. | Bethlehem | Pennsylvania | 18017 | — |
| UT Southwestern Medical Center Investigation Drug Service | Dallas | Texas | 75390 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Gastroenterology Consultants of SA | Live Oak | Texas | 78233 | — |
| Bon Secours St. Mary's Immaculate Hospital | Newport News | Virginia | 23602 | — |
| University of Washington | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02955602, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 14, 2022 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02955602 live on ClinicalTrials.gov.